Shares of Valeant Pharmaceuticals fell in after-hours trading on a report that a bond financier might call a default. Top News & & Analysis
Read More »Activist Ackman trims Valeant stake to 8.5%
Activist financier Expense Ackman has trimmed his stake in embattled drugmaker Valeant Pharmaceuticals. Top News & & Analysis
Read More »Valeant, Ackman must face insider trading suit
The lawsuit accuses Valeant and Ackman of expert trading in Allergan prior to making an unsuccessful takeover bid for the company. Top News & & Analysis
Read More »Former Valeant top executive is mum on Philidor
Valeant'' s stock has plunged on the heels of issues about the drugmaker'' s transactions with an outside pharmacy. Top News & & Analysis
Read More »Drugmaker Valeant to buy Salix for $14.5 billion
Salix, a maker of intestinal drugs that has been courted by at least 4 prospective suitors over the last year, has lastly found a buyer. Top News & & Evaluation
Read More »Drugmaker Valeant to purchase Salix for $10.1 B: Sources
The all-cash offer could be revealed as quickly as Sunday, according to these sources who requested not to be determined. World News & & Evaluation
Read More »